Lv5
1260 积分 2023-09-08 加入
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option
12天前
已完结
Immune-Mediated Diabetes Mellitus, Diabetic Ketoacidosis, Enteritis, and Thrombotic Thrombocytopenic Purpura Presenting as Adverse Effects of Pembrolizumab Therapy
12天前
已完结
Immune-related adverse events associated with cancer immunotherapy
12天前
已完结
Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board
12天前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
12天前
已完结
Management of Immunotherapy-induced Type 1 Diabetes
12天前
已完结
A case of diabetic ketoacidosis triggered by immune checkpoint inhibitors in the treatment of recurrent nasopharyngeal carcinoma
12天前
已完结
Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus
12天前
已完结
Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma
12天前
已完结
A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone
皖公网安备34019202002308
